Anticonvulsant action of the beta-carboline abecarnil: studies in rodents and baboon, Papio papio.

Abecarnil (ZK 112119; isopropyl-6-benzyloxy-4-methoxymethyl-beta-carboxylate) is a metabolically stable beta-carboline derivative with potent anxiolytic and few sedative and ataxic effects in rodents. The anticonvulsant and muscle relaxant actions of abecarnil have been evaluated in mice, rats, gerbils and baboons. Abecarnil raised the threshold for tonic electroconvulsions in mice after corneal but not after auricular application, had no effect on maximal electroshock-induced tonic convulsions triggered by either method, protected mice against the tonic hindlimb extension in PTZ-, picrotoxin- and 3-mercaptopropionate-induced seizures and blocked clonus after PTZ, DMCM (methyl-4-ethyl-6,7-dimethoxy-9H-pyrido-(3,4-b)-indol-3-carboxylate) and 3-mercaptopropionate. Abecarnil had no effect on convulsions induced by bicuculline and strychnine. Furthermore, abecarnil blocked kindled seizures after chronic administration of PTZ and FG 7142 (beta-carboline-3-carboxylic acid methylamide) and protected mice and rats against limbic convulsions induced by pilocarpine. Severity and afterdischarge duration of amygdala-kindled seizures were reduced in rats treated with abecarnil. Abecarnil also antagonized selectively convulsions induced by i.c.v. administration of kainate, but not those triggered by N-methyl-D-aspartate or quisqualate. In genetic models of reflex epilepsy, abecarnil was effective against sound-induced convulsions in DBA/2 mice, against air blast-induced generalized seizures in gerbils and against myoclonus in baboons Papio papio. The anticonvulsant effect of abecornil in a PTZ seizure model in mice was potentiated by ethosuximide, whereas no significant potentiation was found with diazepam, clonazepam, diphenylhydantoin, carbamazepine and phenobarbital. Electromyographic monitoring in a etorphine model of muscle rigidity in rats showed no or little muscle relaxant effect of abecarnil.(ABSTRACT TRUNCATED AT 250 WORDS)

• Publication year

  1990

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  1990-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/s0022-3565(25)12467-1PMID 1970362
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Abecarnil, a metabolically stable, anxioselective beta-carboline acting at benzodiazepine receptors.

  1990cited by this paper
• Blockade of FG 7142 kindling by anticonvulsants acting at sites distant from the benzodiazepine receptor.

  1989cited by this paper
• Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology

  1989cited by this paper
• Electrophysiology of benzodiazepine receptor ligands: multiple mechanisms and sites of action.

  1988cited by this paper
• Bidirectional effects of beta-carbolines and benzodiazepines on cognitive processes.

  1987cited by this paper
• Bidirectional effects of beta-carbolines in reflex epilepsy.

  1987cited by this paper
• Benzodiazepine Receptors and Their Relationship to the Treatment of Epilepsy

  1986cited by this paper
• Effect of stimulus intensity on the profile of anticonvulsant activity of phenytoin, ethosuximide and valproate.

  1985cited by this paper
• Anticonvulsant action of beta-kainic acid in mice. Is beta-kainic acid an N-methyl-D-aspartate antagonist?

  1985cited by this paper
• Evaluation of different GABA receptor agonists in the kindled amygdala seizure model in rats.

  1985cited by this paper
• Acute and chronic effects of the benzodiazepine receptor ligand FG 7142: proconvulsant properties and kindling

  1984cited by this paper
• Audiogenic seizures in DBA/2 mice discriminate sensitively between low efficacy benzodiazepine receptor agonists and inverse agonists.

  1983cited by this paper
• Reversal of the muscle relaxant effect of diazepam by the specific benzodiazepine antagonist Ro 15-1788: an electromyographic study in morphine model of muscular rigidity in rats.

  1983cited by this paper
• Anticonvulsant action in the photosensitive baboon, Papio papio, of a novel beta-carboline derivative, ZK 91296.

  1983cited by this paper
• DMCM: a potent convulsive benzodiazepine receptor ligand.

  1983cited by this paper
• Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study.

  1983cited by this paper
• Micromolar affinity benzodiazepine receptors: identification and characterization in central nervous system.

  1982cited by this paper
• Interaction of convulsive ligands with benzodiazepine receptors.

  1982cited by this paper
• A three-state model of the benzodiazepine receptor explains the interactions between the benzodiazepine antagonist Ro 15-1788, benzodiazepine tranquilizers, β-carbolines, and phenobarbitone

  1982cited by this paper
• Interaction of diphenylhydantoin and benzodiazepines in the CNS.

  1980cited by this paper
• Urinary and brain beta-carboline-3-carboxylates as potent inhibitors of brain benzodiazepine receptors.

  1980cited by this paper
• Correlation between benzodiazepine receptor occupation and anticonvulsant effects of diazepam

  1979cited by this paper
• Benzodiazepine receptor: demonstration in the central nervous system

  1977cited by this paper
• Effect of anticonvulsants on seizures developing in the course of daily administration of pentetrazol to rats.

  1977cited by this paper
• Benzodiazepine receptors in rat brain

  1977cited by this paper
• A primate model for testing anticonvulsant drugs.

  1975cited by this paper
• The Gerbil as a Model for the Study of the Epilepsies

  1974cited by this paper
• Modification of seizure activity by electrical stimulation. II. Motor seizure.

  1972cited by this paper
• Convulsive effects of 4-deoxypyridoxine and of bicuculline in photosensitive baboons (Papio papio) and in rhesus monkeys (Macaca mulatta).

  1971cited by this paper
• A simplified method of evaluating dose-effect experiments.

  1948cited by this paper

• ENX‐101, a GABAA receptor α2,3,5‐selective positive allosteric modulator, displays antiseizure effects in rodent seizure and epilepsy models

  2025cites this paper
• β-Carboline: a privileged scaffold from nature for potential antimalarial activity.

  2025cites this paper
• New epilepsy therapies in development

  2024cites this paper
• Deep brain stimulation of the anterior thalamus attenuates PTZ kindling with concomitant reduction of adenosine kinase expression in rats

  2022cites this paper
• Dogs as a Natural Animal Model of Epilepsy

  2022cites this paper
• A transition metal-free approach towards synthesis of β-carboline tethered 1,3,4-oxadiazoles via oxidative C–O bond formation

  2019cites this paper
• Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Characterization in Rodent Seizure and Epilepsy Models

  2019cites this paper
• 1(3)‐Formyl‐β‐carbolines: Potential Aldo‐X Precursors for the Synthesis of β‐Carboline‐Based Molecular Architectures

  2018cites this paper
• In(OTf)3 assisted synthesis of β-carboline C-3 tethered imidazo[1,2-a]azine derivatives

  2017cites this paper
• Single dose efficacy evaluation of two partial benzodiazepine receptor agonists in photosensitive epilepsy patients: A placebo-controlled pilot study.

  2016cites this paper
• Metal-free 1,3-dipolar cycloaddition approach towards the regioselective synthesis of β-carboline and isoxazole based molecular hybrids

  2016cites this paper
• Natural product inspired design and synthesis of β-carboline and γ-lactone based molecular hybrids.

  2016cites this paper
• Cross-species pharmacological characterization of the allylglycine seizure model in mice and larval zebrafish.

  2015cites this paper
• Convenient synthesis of 1-aryl-9H-β-carboline-3-carbaldehydes and their transformation into dihydropyrimidinone derivatives by Biginelli reaction

  2014cites this paper
• Molecular mechanisms of antiseizure drug activity at GABAA receptors.

  2013cites this paper
• The Pharmacology of Imepitoin: The First Partial Benzodiazepine Receptor Agonist Developed for the Treatment of Epilepsy

  2013cites this paper
• Molecular targets for antiepileptic drug development

  2011cites this paper
• Effects of Hypnotics on Sleep and Quality of Life in Insomnia

  2008cites this paper
• 7 of Hypnotics on Sleep and Quality of Life in Insomnia

  2008cites this paper
• From the Behavioral Pharmacology of Beta-Carbolines to Seizures, Anxiety, and Memory

  2007cites this paper
• Pharmacology of the GABAA Receptor

  2007cites this paper
• CHAPTER 21 – Inherited Epilepsy in Mongolian Gerbils

  2006cites this paper
• Interactions of theβ carboline abecarnil with the high pressure neurological syndrome in a primate model

  2005cites this paper
• Abecarnil and palatability: taste reactivity in normal ingestion in male rats.

  2005cites this paper
• Anxioselective anxiolytics: can less be more?

  2004cites this paper
• COX-2 Inhibitors

  2004cites this paper
• Anti-epileptic drugs as possible neuroprotectants in cerebral ischemia.

  2003cites this paper
• Anticonvulsant Effect of Flutamide on Seizures Induced by Pentylenetetrazole: Involvement of Benzodiazepine Receptors

  2003cites this paper
• Do preclinical seizure models preselect certain adverse effects of antiepileptic drugs.

  2002cites this paper
• SL651498: an anxioselective compound with functional selectivity for alpha2- and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptors.

  2001cites this paper
• SL651498: An Anxioselective Compound with Functional Selectivity for α2- and α3-Containing γ-Aminobutyric AcidA (GABAA) Receptors

  2001cites this paper
• Chronic modulation of the GABA(A) receptor complex regulates Y1 receptor gene expression in the medial amygdala of transgenic mice.

  2000cites this paper
• Abecarnil and alprazolam reverse anxiety-like behaviors induced by ethanol withdrawal.

  2000cites this paper
• Pontine tegmentum lesions increase anxiety-like behavior in rats: a comparison with anxiety produced by beta-CCE.

  2000cites this paper
• Subtype-selective benzodiazepine receptor ligands

  2000cites this paper
• Agonist efficacy, drug dependence, and medications development: preclinical evaluation of opioid, dopaminergic, and GABAA-ergic ligands

  2000cites this paper
• Pontine Tegmentum Lesions Increase Anxiety-Like Behavior in Rats: A Comparison With Anxiety Produced by β-CCE

  2000cites this paper
• Reduction of pentylenetetrazol-induced convulsions by the octadecaneuropeptide ODN.

  1999cites this paper
• Comparison of the pharmacological properties of classical and novel BZ-omega receptor ligands.

  1999cites this paper
• The use and development of anxiolytics in Japan.

  1999cites this paper
• Abecarnil enhances recovery from diazepam tolerance.

  1999cites this paper
• Piperazine imidazo[1,5-a]quinoxaline ureas as high-affinity GABAA ligands of dual functionality.

  1999cites this paper
• An update on GABAA receptors.

  1999cites this paper
• Full-length review An update on GABA receptorsA

  1999cites this paper
• Kainate and AMPA receptor binding in seizure-prone and seizure-resistant inbred mouse strains.

  1998cites this paper
• Abecarnil, a new beta-carboline, in the treatment of anxiety disorders

  1998cites this paper
• Synthesis and evaluation of analogues of the partial agonist 6-(propyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (6-PBC) and the full agonist 6-(benzyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (Zk 93423) at wild type and recombinant GABAA receptors.

  1998cites this paper
• Frontal versus transcorneal stimulation to induce maximal electroshock seizures or kindling in mice and rats.

  1998cites this paper
• Psychomotor effects of the anxiolytic abecarnil: a comparison with lorazepam

  1997cites this paper
• Alprazolam dependence prevented by substituting with the β-carboline abecarnil

  1997cites this paper
• Pharmacology of mammalian GABA-A receptors

  1997cites this paper
• Alprazolam dependence prevented by substituting with the beta-carboline abecarnil.

  1997cites this paper
• Pharmacology of the AMPA Antagonist 2,3‐Dihydroxy‐6‐Nitro‐7‐Sulfamoylbenzo‐(F)‐Quinoxaline

  1997cites this paper
• A double-blind comparison of abecarnil and diazepam in the treatment of uncomplicated alcohol withdrawal

  1997influential citation
• Effect of Pentylenetetrazole‐Induced Kindling on Acetylcholine Release in the Hippocampus of Freely Moving Rats

  1997cites this paper
• Abecarnil, a β-carboline derivative, does not exhibit anticonvulsant tolerance or withdrawal effects in mice

  1996cites this paper
• Chronic treatment with diazepam or abecarnil differently affects the expression of GABAA receptor subunit mRNAs in the rat cortex.

  1996cites this paper
• Abecarnil, a beta-carboline derivative, does not exhibit anticonvulsant tolerance or withdrawal effects in mice.

  1996cites this paper
• Pharmacokinetics of abecarnil in patients with renal insufficiency

  1996cites this paper
• High-affinity partial agonist imidazo[1,5-a]quinoxaline amides, carbamates, and ureas at the gamma-aminobutyric acid A/benzodiazepine receptor complex.

  1996cites this paper
• Anticonvulsant profile of the imidazoquinazolines NNC 14-0185 and NNC 14-0189 in rats and mice.

  1996cites this paper
• Update on the Mechanism of Action of Antiepileptic Drugs

  1996cites this paper
• Failure of Chronic Treatment with Abecarnil to Induce Contingent and Noncontingent Tolerance in Pentylenetetrazol‐Kindled Rats

  1996cites this paper
• Antagonism of isoniazid-induced convulsions by abecarnil in mice tolerant to diazepam.

  1995cites this paper
• Kindling Increases the Sensitivity of Rats to Adverse Effects of Certain Antiepileptic Drugs

  1995cites this paper
• Abecarnil and alprazolam in humans: behavioral, subjective and reinforcing effects.

  1995cites this paper
• Anticonvulsant Actions of Novel and Reference Adenosine Agonists

  1995cites this paper
• Abecarnil in Generalised Anxiety Disorder

  1995cites this paper
• Modulation of basal and stress-induced release of acetylcholine and dopamine in rat brain by abecarnil and imidazenil, two anxioselective gamma-aminobutyric acidA receptor modulators.

  1995cites this paper
• Discriminative stimulus effects of midazolam and abecarnil in rats treated chronically with diazepam or abecarnil

  1995cites this paper
• Abecarnil enhances GABA-induced currents in acutely isolated cerebellar Purkinje cells.

  1995cites this paper
• Abecarnil in Generalised Anxiety Disorder An Initial Appraisal of its Clinical Potential

  1995cites this paper
• Future directions in anxiolytic pharmacotherapy.

  1995cites this paper
• Long-term treatment with abecarnil fails to induce tolerance in mice.

  1994cites this paper
• Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation?

  1994cites this paper
• Pharmacological characterization of the novel anxiolytic beta-carboline abecarnil in rodents and primates.

  1994cites this paper
• Differential effects of abecarnil on basal release of acetylcholine and dopamine in the rat brain.

  1994cites this paper
• Lack of effect of lamotrigine against HPNS in rodent and primate models.

  1994cites this paper
• The pharmacological properties of Y‐23684, a benzodiazepine receptor partial agonist

  1994cites this paper
• Comparison of several benzodiazepine receptor ligands in two models of anxiolytic activity in the mouse: an analysis based on fractional receptor occupancies

  1994cites this paper
• Chronic pharmacological activities of the novel anxiolytic beta-carboline abecarnil in rats.

  1994cites this paper
• Recent developments in the behavioral pharmacology of benzodiazepine (omega) receptors: evidence for the functional significance of receptor subtypes.

  1994cites this paper
• Full and partial agonism displayed by benzodiazepine receptor ligands at recombinant gamma-aminobutyric acidA receptor subtypes.

  1993cites this paper
• Modulation of the seizure threshold for excitatory amino acids in mice by antiepileptic drugs and chemoconvulsants.

  1993cites this paper
• Effect of the beta-carboline abecarnil on spinal reflexes in mice and on muscle tone in genetically spastic rats: a comparison with diazepam.

  1993cites this paper
• Pharmacological evidence for full agonist activity of abecarnil at certain GABAA receptors.

  1993cites this paper
• Human studies on abecarnil a new beta-carboline anxiolytic: safety, tolerability and preliminary pharmacological profile.

  1993cites this paper
• Pharmacokinetics of two partial benzodiazepine receptor agonistic beta-carboline derivatives in healthy volunteers.

  1993cites this paper
• Abecarnil: a novel anxiolytic with mixed full agonist/partial agonist properties in animal models of anxiety and sedation.

  1993cites this paper
• The rapidly expanding range of neuronal benzodiazepine receptor ligands.

  1993cites this paper
• Abecarnil shows reduced tolerance development and dependence potential in comparison to diazepam: animal studies.

  1993cites this paper
• Abecarnil: A New ß-Carboline Anxiolytic Preliminary Clinical Pharmacology

  1993cites this paper
• RP 59037 and RP 60503: anxiolytic cyclopyrrolone derivatives with low sedative potential. interaction with the gamma-aminobutyric acidA/benzodiazepine receptor complex and behavioral effects in the rodent.

  1993cites this paper
• Abecarnil: a new beta-carboline anxiolytic preliminary clinical pharmacology.

  1993cites this paper
• Anxiolytic β-Carbolines

  1993influential citation
• Long-term treatment with abecarnil does not induce diazepam-like dependence in mice.

  1993cites this paper
• Seizures Induced by Pilocarpine: Relevance in Epilepsy

  1992cites this paper
• A review of recently-developed ligands for neuronal benzodiazepine receptors and their pharmacological activities.

  1992cites this paper
• Withdrawal precipitation by benzodiazepine receptor antagonists in dogs chronically treated with diazepam or the novel anxiolytic and anticonvulsant β-carboline abecarnil

  1992cites this paper
• Effects of the β-carboline abecar on epileptic activity, EEG sleep and behavior of rats

  1992cites this paper